Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jun;61(6):1333-1343.
doi: 10.1007/s00125-018-4596-0. Epub 2018 Mar 27.

Overweight, obesity and the risk of LADA: results from a Swedish case-control study and the Norwegian HUNT Study

Affiliations

Overweight, obesity and the risk of LADA: results from a Swedish case-control study and the Norwegian HUNT Study

Rebecka Hjort et al. Diabetologia. 2018 Jun.

Abstract

Aims/hypothesis: Excessive weight is a risk factor for type 2 diabetes, but its role in the promotion of autoimmune diabetes is not clear. We investigated the risk of latent autoimmune diabetes in adults (LADA) in relation to overweight/obesity in two large population-based studies.

Methods: Analyses were based on incident cases of LADA (n = 425) and type 2 diabetes (n = 1420), and 1704 randomly selected control participants from a Swedish case-control study and prospective data from the Norwegian HUNT Study including 147 people with LADA and 1,012,957 person-years of follow-up (1984-2008). We present adjusted ORs and HRs with 95% CI.

Results: In the Swedish data, obesity was associated with an increased risk of LADA (OR 2.93, 95% CI 2.17, 3.97), which was even stronger for type 2 diabetes (OR 18.88, 95% CI 14.29, 24.94). The association was stronger in LADA with low GAD antibody (GADA; <median) (OR 4.25; 95% CI 2.76, 6.52) but present also in LADA with high GADA (OR 2.14; 95% CI 1.42, 3.24). In the Swedish data, obese vs normal weight LADA patients had lower GADA levels, better beta cell function, and were more likely to have low-risk HLA-genotypes. The combination of overweight and family history of diabetes (FHD) conferred an OR of 4.57 (95% CI 3.27, 6.39) for LADA and 24.51 (95% CI 17.82, 33.71) for type 2 diabetes. Prospective data from HUNT indicated even stronger associations; HR for LADA was 6.07 (95% CI 3.76, 9.78) for obesity and 7.45 (95% CI 4.02, 13.82) for overweight and FHD.

Conclusions/interpretation: Overweight/obesity is associated with increased risk of LADA, particularly when in combination with FHD. These findings support the hypothesis that, even in the presence of autoimmunity, factors linked to insulin resistance, such as excessive weight, could promote onset of diabetes.

Keywords: ANDIS; ANDiU; Body mass index; Case–control study; ESTRID; HUNT Study; LADA; Latent autoimmune diabetes in adults; Prospective study; Type 2 diabetes.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no duality of interest associated with this manuscript.

Figures

Fig. 1
Fig. 1
ORs with 95% CIs for (a) LADA, (b) type 2 diabetes, (c) LADAhigh, and (d) LADAlow by BMI (kg/m2) fitted with restricted cubic splines using data from ESTRID 2010–2016. The reference value is BMI 23 kg/m2 and models were adjusted for age, sex, FHD, physical activity level and smoking. Black solid lines represent the spline line, long dashed lines represent the 95% CIs of the spline line and the red dotted lines represent the linear line. The histogram at the bottom of each figure part represents the distribution of BMI in the study population. The left y-axes are on a loge scale
Fig. 2
Fig. 2
ORs for (a) LADA and (b) type 2 diabetes in ESTRID. HRs for (c) LADA and (d) type 2 diabetes in HUNT by combinations of overweight/obesity (BMI ≥ 25 kg/m2) and FHD. The reference is normal weight (BMI < 25 kg/m2) and no FHD. The y-axis is on the log10 scale and error bars are 95% CI

References

    1. Abdullah A, Peeters A, de Courten M, Stoelwinder J. The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies. Diabetes Res Clin Pract. 2010;89:309–319. doi: 10.1016/j.diabres.2010.04.012. - DOI - PubMed
    1. Hardy OT, Czech MP, Corvera S. What causes the insulin resistance underlying obesity? Curr Opin Endocrinol Diabetes Obes. 2012;19:81–87. doi: 10.1097/MED.0b013e3283514e13. - DOI - PMC - PubMed
    1. Wilkin TJ. The accelerator hypothesis: a review of the evidence for insulin resistance as the basis for type I as well as type II diabetes. Int J Obes. 2009;33:716–726. doi: 10.1038/ijo.2009.97. - DOI - PubMed
    1. Fourlanos S, Narendran P, Byrnes GB, Colman PG, Harrison LC. Insulin resistance is a risk factor for progression to type 1 diabetes. Diabetologia. 2004;47:1661–1667. doi: 10.1007/s00125-004-1507-3. - DOI - PubMed
    1. Xu P, Cuthbertson D, Greenbaum C, Palmer JP, Krischer JP, Diabetes Prevention Trial-Type 1 Study Group Role of insulin resistance in predicting progression to type 1 diabetes. Diabetes Care. 2007;30:2314–2320. doi: 10.2337/dc06-2389. - DOI - PubMed

Publication types

MeSH terms